Filla Laura A, Yuan Wei, Feldman Eva L, Li Shuwei, Edwards James L
Department of Chemistry, Saint Louis University , St. Louis, Missouri 63103, United States.
J Proteome Res. 2014 Dec 5;13(12):6121-34. doi: 10.1021/pr501030e. Epub 2014 Nov 13.
Despite the prevalence of diabetes and the global health risks it poses, the biochemical pathogenesis of diabetic complications remains poorly understood with few effective therapies. This study employs capillary liquid chromatography (capLC) and tandem mass spectrometry (MS/MS) in conjunction with both global metabolomics and isobaric tags specific to amines and carbonyls to probe aortic metabolic content in diabetic mice with hyperglycemia, hyperlipidemia, hypertension, and stenotic vascular damage. Using these combined techniques, metabolites well-characterized in diabetes as well as novel pathways were investigated. A total of 53,986 features were detected, 719 compounds were identified as having significant fold changes (thresholds ≥ 2 or ≤ 0.5), and 48 metabolic pathways were found to be altered with at least 2 metabolite hits in diabetic samples. Pathways related to carbonyl stress, carbohydrate metabolism, and amino acid metabolism showed the greatest number of metabolite changes. Three novel pathways with previously limited or undescribed roles in diabetic complications--vitamin B6, propanoate, and butanoate metabolism--were also shown to be altered in multiple points along the pathway. These discoveries support the theory that diabetic vascular complications arise from the interplay of a myriad of metabolic pathways in conjunction with oxidative and carbonyl stress, which may provide not only new and much needed biomarkers but also insights into novel therapeutic targets.
尽管糖尿病普遍存在且对全球健康构成风险,但糖尿病并发症的生化发病机制仍知之甚少,有效治疗方法也寥寥无几。本研究采用毛细管液相色谱(capLC)和串联质谱(MS/MS),结合整体代谢组学以及胺类和羰基类特异性等压标记,来探究患有高血糖、高血脂、高血压和血管狭窄损伤的糖尿病小鼠的主动脉代谢成分。利用这些联合技术,对糖尿病中特征明确的代谢物以及新的代谢途径进行了研究。总共检测到53986个特征峰,719种化合物被鉴定为具有显著的倍数变化(阈值≥2或≤0.5),并且发现48条代谢途径在糖尿病样本中至少有2种代谢物命中而发生改变。与羰基应激、碳水化合物代谢和氨基酸代谢相关的途径显示出最多的代谢物变化。在糖尿病并发症中作用先前有限或未被描述的三条新途径——维生素B6、丙酸和丁酸代谢——也显示在该途径的多个点上发生了改变。这些发现支持了这样一种理论,即糖尿病血管并发症源于多种代谢途径与氧化应激和羰基应激的相互作用,这不仅可能提供新的急需的生物标志物,还能为新的治疗靶点提供见解。